Cargando…
Effect and Safety of Mycophenolate Mofetil or Sodium in Systemic Sclerosis-Associated Interstitial Lung Disease: A Meta-Analysis
Background. Interstitial lung disease (ILD) is the most common complication of systemic sclerosis (SSc) with treatment ineffective. Objective: The aim of this meta-analysis was to provide an estimate of the safety and efficacy profile of Mycophenolate Mofetil (MMF) or sodium (MMS) in SSc-ILD patient...
Autores principales: | Tzouvelekis, Argyris, Galanopoulos, Nikolaos, Bouros, Evangelos, Kolios, George, Zacharis, George, Ntolios, Paschalis, Koulelidis, Andreas, Oikonomou, Anastasia, Bouros, Demosthenes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357562/ https://www.ncbi.nlm.nih.gov/pubmed/22655194 http://dx.doi.org/10.1155/2012/143637 |
Ejemplares similares
-
Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2011) -
Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal
por: Tzouvelekis, Argyris, et al.
Publicado: (2011) -
A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2013) -
Idiopathic Pulmonary Hemosiderosis in Adults: A Case Report and Review of the Literature
por: Tzouvelekis, Argyris, et al.
Publicado: (2012) -
Endotyping of progressive fibrotic interstitial lung diseases: It is the final destination that matters and not the journey
por: Tzouvelekis, Argyris, et al.
Publicado: (2020)